These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21118731)

  • 1. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves.
    Naso F; Gandaglia A; Iop L; Spina M; Gerosa G
    Acta Biomater; 2011 Apr; 7(4):1728-34. PubMed ID: 21118731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves.
    Choi SY; Jeong HJ; Lim HG; Park SS; Kim SH; Kim YJ
    J Heart Valve Dis; 2012 May; 21(3):387-97. PubMed ID: 22808845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery.
    Konakci KZ; Bohle B; Blumer R; Hoetzenecker W; Roth G; Moser B; Boltz-Nitulescu G; Gorlitzer M; Klepetko W; Wolner E; Ankersmit HJ
    Eur J Clin Invest; 2005 Jan; 35(1):17-23. PubMed ID: 15638815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
    Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
    Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Gal detectors in xenotransplantation research: a word of caution.
    Naso F; Gandaglia A; Iop L; Spina M; Gerosa G
    Xenotransplantation; 2012; 19(4):215-20. PubMed ID: 22909134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the alpha-gal epitope on adult porcine bone tissue.
    Feng W; Lian Y; Zhou Z; Lu Y; Li S; Pei F; Cheng J
    Transplant Proc; 2006 Sep; 38(7):2247-51. PubMed ID: 16980056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves.
    Bloch O; Golde P; Dohmen PM; Posner S; Konertz W; Erdbrügger W
    Tissue Eng Part A; 2011 Oct; 17(19-20):2399-405. PubMed ID: 21557643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xenogeneic antigens and immune response in pig to man xenograft].
    Li T; Li Y; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jan; 12(1):42-7. PubMed ID: 10374623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenoantigenicity of porcine decellularized valves.
    Helder MRK; Stoyles NJ; Tefft BJ; Hennessy RS; Hennessy RRC; Dyer R; Witt T; Simari RD; Lerman A
    J Cardiothorac Surg; 2017 Jul; 12(1):56. PubMed ID: 28716099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure.
    Xu H; Wan H; Zuo W; Sun W; Owens RT; Harper JR; Ayares DL; McQuillan DJ
    Tissue Eng Part A; 2009 Jul; 15(7):1807-19. PubMed ID: 19196142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of α-Gal Antigen Removal in the Porcine Dermal Tissue by α-Galactosidase.
    Gao HW; Li SB; Sun WQ; Yun ZM; Zhang X; Song JW; Zhang SK; Leng L; Ji SP; Tan YX; Gong F
    Tissue Eng Part C Methods; 2015 Nov; 21(11):1197-204. PubMed ID: 26140655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
    Unfer RC; Hellrung D; Link CJ
    Cancer Res; 2003 Mar; 63(5):987-93. PubMed ID: 12615713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
    Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
    J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.
    Juthier F; Vincentelli A; Gaudric J; Corseaux D; Fouquet O; Calet C; Le Tourneau T; Soenen V; Zawadzki C; Fabre O; Susen S; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):843-52. PubMed ID: 16580443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves.
    Kasimir MT; Rieder E; Seebacher G; Wolner E; Weigel G; Simon P
    Tissue Eng; 2005; 11(7-8):1274-80. PubMed ID: 16144463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-Gal specific IgG immune response after implantation of bioprostheses.
    Mangold A; Szerafin T; Hoetzenecker K; Hacker S; Lichtenauer M; Niederpold T; Nickl S; Dworschak M; Blumer R; Auer J; Ankersmit HJ
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):191-5. PubMed ID: 19670109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.